Concepedia

Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease

Yolanda Gómez‐Gálvez, Cristina Palomo‐Garo, Javier Fernández‐Ruíz, Concepción García

Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2015 · 213 citations · 34 references

DOI

Concepts

References

34

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Gabriel T. Liberatore, Vernice Jackson‐Lewis, Slobodanka Vukosavić et al. · Nature Medicine · 1999 · 1K citations

, , +16

Microglial activation and dopamine terminal loss in early Parkinson's disease

Yasuomi Ouchi, Etsuji Yoshikawa, Yoshimoto Sekine et al. · Annals of Neurology · 2005 · 835 citations

, , +17

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

Lisa Walter, Allyn Franklin, Anke Witting et al. · Journal of Neuroscience · 2003 · 663 citations · Full text

, , +17

Cannabinoid CB<sub>2</sub>Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

Cristina Benito, Estefanía Núñez, Rosa M. Tolón et al. · Journal of Neuroscience · 2003 · 618 citations · Full text

, , +17

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor

Nancy E. Buckley, Kathleen L. McCoy, Éva Mezey et al. · European Journal of Pharmacology · 2000 · 542 citations

, , +6